CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million. New company is named NeuroGen Pharma, led by an experienced management team with a strong track ...
The complexity of the central nervous system (CNS) and its pathologies necessitates an intricate understanding of the cellular and molecular mechanisms at play. Single-cell biology has emerged as a ...